Skip to main content
Clinical Trials/NCT02984033
NCT02984033
Withdrawn
Not Applicable

Quality of Life and Psychological Evaluation of Patients Affected by Head and Neck Cancer Treated With Curative Intent: Multicentric Prospective Study

Michele Tedeschi1 site in 1 countryNovember 2016
ConditionsQuality of Life

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Quality of Life
Sponsor
Michele Tedeschi
Locations
1
Primary Endpoint
Quality of life and psychological effetcs evaluated by patient reported outcome (PRO)
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

The prospective trial is to describe the quality of life and psychological effects in patients with head and neck tumor receiving curative intent treatment

Detailed Description

The multicentric prospective trial is to evaluate the quality of life and psychological effects in patients with head and neck tumor treated by curative intent radiation therapy. The treatment consists in a conventionally fractionated Intensity Modulated Radiotherapy (IMRT) or until 2.2 Gy per fraction with a total dose of 50-66 Gy in post-operative setting and 66-72 Gy in radical setting.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
February 1, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Michele Tedeschi
Responsible Party
Sponsor Investigator
Principal Investigator

Michele Tedeschi

Medical Doctor

Istituto Clinico Humanitas

Eligibility Criteria

Inclusion Criteria

  • Squamous cell carcinoma of head and neck (oral cavity, larynx, pharynx and hypopharynx) in non-metastatic staging;
  • curative intent treatment (radiation therapy associated or not to chemotherapy; surgery associated or not to post-operative radiotherapy and chemotherapy);
  • performance status \< 2;
  • age ≥ 18 years;
  • good knowledge of italian language;
  • written informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Quality of life and psychological effetcs evaluated by patient reported outcome (PRO)

Time Frame: 18 months

Study Sites (1)

Loading locations...

Similar Trials